In the media December 22, 2021
Proof-of-concept research on Deep TMS as a treatment for alcohol dependence, with commentary from Dr....
News December 9, 2021
Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol...
In the media December 1, 2021
A behind the curtains look at Deep TMS treatment and how it is currently providing relief for a local...
In the media October 26, 2021
The importance of mental health is highlighted, with statements from BrainsWay and Chief Medical Officer...
News November 30, 2021
BURLINGTON, Mass. and JERUSALEM, November 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...
News November 17, 2021
Revenue Growth of 34% Year-over-Year in Q3 2021 Received Regulatory Clearance for Deep TMS™ System...
News November 3, 2021
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News October 12, 2021
Zafiris Daskalakis, MD, PhD to Bring Extensive Research and Clinical Expertise to Assist in Guiding Growth...
News September 30, 2021
Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction BURLINGTON,...
In the media September 20, 2021
Patient testimonials, smoker statistics, and discussion around BrainsWay’s Deep TMS smoking addiction...
In the media September 20, 2021
Highlighting the recent FDA clearance for anxious depression with references to the study and a quote...
In the media September 9, 2021
Dr. Tendler discusses how emerging technologies, such as BrainsWay’s Deep TMS™, offer hope to...
In the media September 7, 2021
BrainsWay CEO and President, Christopher von Jako, PhD discusses the navigation, education, and partner...
News September 9, 2021
BURLINGTON, Mass. and JERUSALEM, Sept. 09, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News August 30, 2021
BURLINGTON, Mass. and JERUSALEM, August 30, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
In the media August 25, 2021
Summary of the release and research lending to the FDA-clearance of anxious depression, with quotes from...
In the media August 20, 2021
Summary of the release, highlighting how this FDA clearance will allow BrainsWay to increase patient...
In the media August 19, 2021
FDA Clearance for Deep TMS system in decreasing anxiety symptoms in depressed patients, as well as highlights...
